Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

NCT03083353 is registered in ClinicalTrials.gov with Jasper A. Smits as lead sponsor.

NCT NCT03083353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03083353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Lead sponsor
Jasper A. Smits
Phase
Phase 1
Overall status
Completed
Start date
January 22, 2020
Completion date
June 14, 2023
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

craving, nicotine dependence, smoking behaviors, smoking cessation, smoking reduction, smoking, cigarette